McCloskey, A G <br/><br/>
Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis.  [electronic resource] 

 -  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences  Jan 2020 
 - 105104 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0720 
<br/><br/><label>Standard No.: </label>10.1016/j.ejps.2019.105104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--pharmacology<br/>Animals<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Enteroendocrine Cells--drug effects<br/>Glucagon-Like Peptide 1--metabolism<br/>Glucose--metabolism<br/>Homeostasis--drug effects<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--metabolism<br/>Insulin-Secreting Cells--drug effects<br/>Male<br/>Mice<br/>Receptors, G-Protein-Coupled--agonists<br/>Sulfonamides--pharmacology